The distribution and correlates of hypomanic personality traits were examined in a representative sample of 1709 adolescents. Hypomanic traits were assessed with an abbreviated version of Eckblad and Chapman's (1986) Hypomanic Personality Scale. Hypomanic traits were normally distributed and were slightly but significantly higher among females. Test-retest stability over a mean 14-month interval was 0.54. High scores were associated with elevated lifetime rates of mood, disruptive behavior and substance use disorders. Among subjects with no history of mood disorder, hypomanic traits were associated with a broad range of indices of psychosocial dysfunction, both concurrently and at 1-year follow-up. In addition, hypomanic personality traits predicted increased levels of impairment in a number of areas, including depressive and internalizing symptomatology, over the course of the follow-up. Finally, among subjects with a past history of major depression, hypomanic traits were associated with a higher level of depression at the initial assessment, greater symptomatology and impairment during their worst episode, and higher rates of attempted suicide, comorbid disruptive behavior disorders and recurrent major depressive episodes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0165-0327(96)00005-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Silence as epistemic agency in mania.
Med Health Care Philos
January 2025
Department of Philosophy, University of Bristol, Bristol, UK.
Silence is a byword for socially imposed harm in the burgeoning literature on epistemic injustice in psychiatry. While some silence is harmful and should be broken, this understanding of silence is untenably simplistic. Crucially, it neglects the possibility that silence can also play a constructive epistemic role in the lives of people with mental illness.
View Article and Find Full Text PDFDissociable ventral and dorsal sensorimotor functional circuits linking the hypomanic personality traits to aggression via behavioral inhibition system.
Int J Clin Health Psychol
January 2025
Faculty of Psychology, Tianjin Normal University, Tianjin, 300387, China.
Article Synopsis
- Hypomanic personality traits (HPT) are linked to higher risk for psychiatric disorders like bipolar disorder and are associated with aggressive behaviors, yet the underlying neuropsychological mechanisms are not fully understood.
- The study used psychometric network analysis to identify key factors (Behavioral Inhibition System and mood volatility) that connect HPT to aggression, finding that mood volatility positively correlates with aggression, with BIS acting as a mediator.
- Further imaging studies revealed distinct functions of the dorsal and ventral sensorimotor cortices in processing rewards, and resting-state imaging confirmed these regions' connections to different brain networks, highlighting the importance of these circuits in mediating the relationship between mood volatility, aggression, and BIS.
Genomics yields biological and phenotypic insights into bipolar disorder.
Nature
January 2025
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Bipolar disorder is a leading contributor to the global burden of disease. Despite high heritability (60-80%), the majority of the underlying genetic determinants remain unknown. We analysed data from participants of European, East Asian, African American and Latino ancestries (n = 158,036 cases with bipolar disorder, 2.
View Article and Find Full Text PDFBecause of γ-Aminobutyric Acid-Glutamate Imbalance, Gut Microbiota, or Both? Delirious Mania Induced by Ciprofloxacin Use: A Case Report and Review of the Literature.
J Psychiatr Pract
January 2025
Department of Psychiatry, School of Medicine, Marmara University, Istanbul, Turkey.
Ciprofloxacin is an antibiotic from the fluoroquinolone group that is frequently used in many clinical practices. In addition to its peripheral neuropathic side effects, it is an antibiotic that can pass through the blood-brain barrier due to its lipophilic features and cause rare central nervous system symptoms. Although cases of neuropsychiatric symptoms developing after treatment with ciprofloxacin have been reported in the literature, the number of reports of manic episodes after ciprofloxacin use is limited, and there have been no reports of delirious mania developing after ciprofloxacin use until the case presented in this report.
View Article and Find Full Text PDFA randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study).
J Psychopharmacol
January 2025
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Background: Options for 'treatment-resistant bipolar depression' (TRBD) are limited. Two small, short-term, trials of pramipexole suggest it might be an option.
Aims: To evaluate the clinical effectiveness and safety of pramipexole in the management of TRBD.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!